Requests for Applications: Biomarkers of Pancreatic Beta Cell Stress and Health
JDRF, the world’s leading non-profit organization with the mission to cure type 1 diabetes (T1D), invites applications from research investigators having interest and expertise to support the discovery and advancement of biomarkers of pancreatic beta cell stress and health correlating with early beta-cell loss.
The purpose of this call for Letters of Intent is to invite proposals to support and advance the discovery, development, and/or validation of biomarkers of pancreatic beta cell stress and dysfunction. Studies based on use or validation with human beta cells/islets and clinical samples or tissues will be of special interest.
MECHANISM
Applications in response to this announcement can be submitted under one of the following funding mechanisms:
Pilot & Feasibility Grants (P&Fs): up to $110,000 (including 10% indirect costs) for one year only.
Strategic Research Agreements (SRAs): Up to $250,000 USD per year including 10% indirect costs
for up to 3 years may be requested. The level of funding will vary depending on the scope and overall objectives of the proposal. Under the terms of the grant award, written quarterly (~2-3 pages) reports will be required from the funded investigator as a basis for continued support.
LETTER OF INTENT
Prospective applicants should submit a letter of intent on -line via the proposalCENTRAL website (https://proposalcentral.altum.com/default.asp).
The LOI template provided on the proposalCENTRAL Web site must be used to complete the application. Applicants will be notified approximately eight weeks after the LOI deadline date if they have been approved to submit a full application.
Letter of Intent Deadline: June 17, 2013.
